Utidelone

优替德隆

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameUtidelone
Drug Alias Name脱环氧埃坡霉素Depoxythilone脱环氧埃博霉素优替帝UTD-1 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMitosis inhibitorsTubulin polymerisation inhibitors
TargetsTubulin
Therapy Area/IndicationsSolid tumoursUterine Cervical NeoplasmsFallopian Tube Neoplasms +[8] 
Global Approved IndicationsBreast Neoplasms
Approved Indications in ChinaBreast Neoplasms
Original Approved Country/TerritoryMainland China
Original Approved Date2021/03/11
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBeijing Biostar Pharmaceuticals Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesBiostar Pharmaceuticals IncZhongnan Hospital Of Wuhan UniversityFudan University +[6] 
Inactive CompaniesN/A
Active IndicationsSolid tumoursUterine Cervical NeoplasmsFallopian Tube Neoplasms +[7] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeL01
Related LinksWikipediaDrugBank